Annual EBIT
-$43.61 M
+$21.20 M+32.71%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual earnings before interest & taxes is -$43.61 million, with the most recent change of +$21.20 million (+32.71%) on December 31, 2023.
- During the last 3 years, TARA annual EBIT has fallen by -$9.67 million (-28.49%).
- TARA annual EBIT is now -457.00% below its all-time high of -$7.83 million, reached on December 31, 2019.
Performance
TARA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$12.33 M
-$1.67 M-15.66%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly earnings before interest & taxes is -$12.33 million, with the most recent change of -$1.67 million (-15.66%) on September 30, 2024.
- Over the past year, TARA quarterly EBIT has dropped by -$1.63 million (-15.23%).
- TARA quarterly EBIT is now -763.02% below its all-time high of -$1.43 million, reached on June 30, 2019.
Performance
TARA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$45.88 M
-$1.63 M-3.68%
September 30, 2024
Summary
- As of February 8, 2025, TARA TTM earnings before interest & taxes is -$45.88 million, with the most recent change of -$1.63 million (-3.68%) on September 30, 2024.
- Over the past year, TARA TTM EBIT has increased by +$25.55 million (+35.77%).
- TARA TTM EBIT is now -3111.52% below its all-time high of -$1.43 million, reached on June 30, 2019.
Performance
TARA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TARA EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +32.7% | -15.2% | +35.8% |
3 y3 years | -28.5% | -15.2% | +35.8% |
5 y5 years | -104.1% | -15.2% | +35.8% |
TARA EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +32.7% | -66.2% | +68.3% | -28.4% | +35.8% |
5 y | 5-year | -457.0% | +32.7% | -389.4% | +68.3% | -628.1% | +35.8% |
alltime | all time | -457.0% | +32.7% | -763.0% | +68.3% | -3111.5% | +35.8% |
Protara Therapeutics EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$12.33 M(+15.7%) | -$45.88 M(+3.7%) |
Jun 2024 | - | -$10.66 M(-10.0%) | -$44.25 M(-3.2%) |
Mar 2024 | - | -$11.85 M(+7.3%) | -$45.73 M(+4.9%) |
Dec 2023 | -$43.61 M(-32.7%) | -$11.04 M(+3.2%) | -$43.61 M(-38.9%) |
Sep 2023 | - | -$10.70 M(-11.9%) | -$71.43 M(+4.8%) |
Jun 2023 | - | -$12.14 M(+24.7%) | -$68.15 M(+6.1%) |
Mar 2023 | - | -$9.73 M(-75.0%) | -$64.20 M(-0.9%) |
Dec 2022 | -$64.81 M(+42.4%) | -$38.86 M(+423.9%) | -$64.81 M(+81.4%) |
Sep 2022 | - | -$7.42 M(-9.5%) | -$35.73 M(-7.4%) |
Jun 2022 | - | -$8.19 M(-20.8%) | -$38.59 M(-9.6%) |
Mar 2022 | - | -$10.35 M(+5.9%) | -$42.68 M(-6.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$45.52 M(+34.1%) | -$9.77 M(-5.0%) | -$45.52 M(+3.0%) |
Sep 2021 | - | -$10.28 M(-16.3%) | -$44.20 M(+5.3%) |
Jun 2021 | - | -$12.28 M(-6.9%) | -$41.98 M(+13.6%) |
Mar 2021 | - | -$13.18 M(+55.9%) | -$36.97 M(+8.9%) |
Dec 2020 | -$33.94 M(+333.5%) | -$8.46 M(+4.9%) | -$33.95 M(+21.2%) |
Sep 2020 | - | -$8.06 M(+11.0%) | -$28.01 M(+25.6%) |
Jun 2020 | - | -$7.27 M(-28.5%) | -$22.30 M(+35.5%) |
Mar 2020 | - | -$10.16 M(+303.3%) | -$16.46 M(+161.2%) |
Dec 2019 | -$7.83 M(-63.4%) | -$2.52 M(+7.0%) | -$6.30 M(+66.6%) |
Sep 2019 | - | -$2.35 M(+64.8%) | -$3.78 M(+164.8%) |
Jun 2019 | - | -$1.43 M | -$1.43 M |
Dec 2018 | -$21.37 M | - | - |
FAQ
- What is Protara Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Protara Therapeutics?
- What is Protara Therapeutics annual EBIT year-on-year change?
- What is Protara Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Protara Therapeutics?
- What is Protara Therapeutics quarterly EBIT year-on-year change?
- What is Protara Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Protara Therapeutics?
- What is Protara Therapeutics TTM EBIT year-on-year change?
What is Protara Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TARA is -$43.61 M
What is the all time high annual EBIT for Protara Therapeutics?
Protara Therapeutics all-time high annual earnings before interest & taxes is -$7.83 M
What is Protara Therapeutics annual EBIT year-on-year change?
Over the past year, TARA annual earnings before interest & taxes has changed by +$21.20 M (+32.71%)
What is Protara Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TARA is -$12.33 M
What is the all time high quarterly EBIT for Protara Therapeutics?
Protara Therapeutics all-time high quarterly earnings before interest & taxes is -$1.43 M
What is Protara Therapeutics quarterly EBIT year-on-year change?
Over the past year, TARA quarterly earnings before interest & taxes has changed by -$1.63 M (-15.23%)
What is Protara Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TARA is -$45.88 M
What is the all time high TTM EBIT for Protara Therapeutics?
Protara Therapeutics all-time high TTM earnings before interest & taxes is -$1.43 M
What is Protara Therapeutics TTM EBIT year-on-year change?
Over the past year, TARA TTM earnings before interest & taxes has changed by +$25.55 M (+35.77%)